{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:04:15Z","timestamp":1762430655474},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.urology.2012.01.068","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T12:49:05Z","timestamp":1337345345000},"page":"162-168","source":"Crossref","is-referenced-by-count":14,"title":["Greater Percent-free Testosterone Is Associated With High-grade Prostate Cancer in Men Undergoing Prostate Biopsy"],"prefix":"10.1016","volume":"80","author":[{"given":"Simone","family":"Albisinni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo","family":"De Nunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tubaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel L.","family":"Banez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.01.068_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eururo.2006.08.048","article-title":"Testosterone and prostate cancer","volume":"51","author":"Tubaro","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.01.068_bib2","first-page":"293","article-title":"Studies on prostatic cancer\u2014I","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.01.068_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2012.01.068_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-410X.2009.08761.x","article-title":"Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk","volume":"105","author":"Morote","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.01.068_bib5","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1055-9965.EPI-04-0715","article-title":"Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy","volume":"14","author":"Parsons","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2012.01.068_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000319966","article-title":"Investigative clinical study on prostate cancer","volume":"85","author":"Porcaro","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2012.01.068_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/pcan.2009.11","article-title":"Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database","volume":"12","author":"Freedland","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2012.01.068_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/jcem-47-2-268","article-title":"Depressed plasma testosterone and fractional binding of testosterone in obese males","volume":"47","author":"Amatruda","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.01.068_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jc.86.2.724","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.01.068_bib10","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1200\/JCO.2005.05.025","article-title":"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study","volume":"23","author":"Freedland","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2012.01.068_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/pcan.2010.15","article-title":"Predicting non-organ-confined prostate cancer in men diagnosed after 2000","volume":"13","author":"Caire","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2012.01.068_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.11572","article-title":"High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study","volume":"108","author":"Stattin","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2012.01.068_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/pcan.2008.35","article-title":"Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?","volume":"12","author":"Imamoto","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2012.01.068_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/01.ju.0000062674.43964.d0","article-title":"Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy","volume":"169","author":"Massengill","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.01.068_bib15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/01.ju.0000181818.51977.29","article-title":"Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer","volume":"174","author":"Teloken","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2012.01.068_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.eururo.2006.08.047","article-title":"The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening","volume":"51","author":"Yano","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.01.068_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.eururo.2004.11.003","article-title":"Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy","volume":"47","author":"Imamoto","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.01.068_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.beem.2004.03.011","article-title":"Androgens and the ageing male","volume":"18","author":"Swerdloff","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.01.068_bib19","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1002\/cncr.24571","article-title":"Obesity as a predictor of adverse outcome across black and white race: results from the shared equal access regional Cancer Hospital (SEARCH) database","volume":"115","author":"Jayachandran","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2012.01.068_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/mend-4-1-22","article-title":"Autologous down-regulation of androgen receptor messenger ribonucleic acid","volume":"4","author":"Quarmby","year":"1990","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.urology.2012.01.068_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1476-4598-7-88","article-title":"Membrane androgen receptor activation triggers down-regulation of PI-3K\/Akt\/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells","volume":"7","author":"Papadopoulou","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.urology.2012.01.068_bib22","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial","volume":"296","author":"Marks","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2012.01.068_bib23","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1158\/0008-5472.CAN-06-3332","article-title":"Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer","volume":"67","author":"Mostaghel","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.01.068_bib24","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2009-2754","article-title":"Low free testosterone predicts frailty in older men: the health in men study","volume":"95","author":"Hyde","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.01.068_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.2008.03365.x","article-title":"Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men","volume":"70","author":"Vanbillemont","year":"2009","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.urology.2012.01.068_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0030-1261918","article-title":"Is hypoandrogenemia a component of metabolic syndrome in males?","volume":"119","author":"Singh","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.urology.2012.01.068_bib27","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2012.01.068_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: a meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"10.1016\/j.urology.2012.01.068_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes","volume":"128","author":"Atchison","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2012.01.068_bib30","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1743-6109.2009.01473.x","article-title":"Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population","volume":"7","author":"Moreno","year":"2010","journal-title":"J Sex Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T05:24:36Z","timestamp":1542950676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429512002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0090429512002439"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.01.068","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}